# OnCo record paper-bratulic-gagome-pnas-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-bratulic-gagome-pnas-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-bratulic-gagome-pnas-2022" ;
  schema:name "Noninvasive detection of any-stage cancer using free glycosaminoglycans"@en ;
  schema:description "Elypta's founding study: patterns of sugar molecules called glycosaminoglycans in urine and blood told people with 14 cancer types from healthy people, including some stage I cancers."@en ;
  schema:url <https://onco.cc/key-papers/paper-bratulic-gagome-pnas-2022/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1073/pnas.2115328119>, <https://pubmed.ncbi.nlm.nih.gov/36469776/> ;
  schema:sameAs <https://doi.org/10.1073/pnas.2115328119> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Bratulic S, Limeta A, Dabestani S, et al." ;
  onco:sections <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:drugs <https://onco.cc/drugs/gagome-mced-test/> ;
  onco:companies <https://onco.cc/companies/elypta/> ;
  onco:journals <https://onco.cc/journals/pnas/> .